1. Home
  2. PBLS vs NHI Comparison

PBLS vs NHI Comparison

Compare PBLS & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

HOLD

Current Price

$25.11

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo National Health Investors Inc.

NHI

National Health Investors Inc.

HOLD

Current Price

$64.89

Market Cap

3.2B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBLS
NHI
Founded
2015
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.2B
IPO Year
2026
1994

Fundamental Metrics

Financial Performance
Metric
PBLS
NHI
Price
$25.11
$64.89
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$41.75
★ $80.88
AVG Volume (30 Days)
★ 910.8K
309.1K
Earning Date
11-17-2026
11-09-2026
Dividend Yield
N/A
★ 5.67%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.97
Revenue
N/A
★ $375,628,000.00
Revenue This Year
N/A
$21.19
Revenue Next Year
$222.58
$5.71
P/E Ratio
★ N/A
$33.61
Revenue Growth
N/A
★ 12.07
52 Week Low
$22.78
$63.51
52 Week High
$42.49
$91.38

Technical Indicators

Market Signals
Indicator
PBLS
NHI
Relative Strength Index (RSI) 36.35 37.07
Support Level N/A $63.51
Resistance Level $41.72 $78.02
Average True Range (ATR) 2.31 1.14
MACD -0.41 0.26
Stochastic Oscillator 28.27 35.69

Price Performance

Historical Comparison
PBLS
NHI

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

About NHI National Health Investors Inc.

National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.

Share on Social Networks: